Tumor Biology

, Volume 36, Issue 3, pp 2033–2039 | Cite as

Association of interleukin 22 polymorphisms with gastric cancer risk

  • Shan-yu Qin
  • Xian-wen Yang
  • Wei Luo
  • Mei Chen
  • Zhi-ling Liu
  • Si-biao Su
  • Hai-xing Jiang
Research Article


Interleukin (IL)-22 has been implicated in inflammation and tumorigenesis. To date, no studies have investigated the role of IL-22 polymorphism in the carcinogenesis of gastric cancer (GC). In this study, we aimed to investigate the association of IL-22 polymorphisms with the risk of GC in a Chinese population. One hundred eight GC patients and 110 healthy controls were included in the study. IL-22 rs1179251, rs2227485, and rs2227473 polymorphisms were determined by PCR amplification and DNA sequencing. Haplotypes were constructed, and a possible association of these haplotypes with GC was assessed. The distribution of IL-22 rs1179251 polymorphism with clinical parameters was also analyzed. The IL-22 rs1179251 polymorphism was significantly associated with an increased risk of GC (p < 0.05). Stratified analysis revealed that rs1179251 was associated with advanced stages, lymph node metastases, and distant metastases of GC (p < 0.05). No associations were found between rs2227485 and rs2227473 and the risk of GC (p > 0.05). Three possible haplotypes (Crs1179251-Crs2227485-Grs2227485, Crs1179251-Trs2227485-Grs2227485, and Grs1179251-Trs2227485-Ars2227485) were identified, but no associations were found between these and the risk of GC (p > 0.05). In summary, our study demonstrates that the rs1179251 polymorphism of IL-22 was associated with an increased risk of GC and may influence the progression of GC. Future larger studies with other ethnic populations are required to confirm these findings.


Interleukin-22 Gastric cancer Polymorphism 



This work was supported by grants from the National Natural Scientific Foundation of China (81260083; 31360221). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Conflict of interest



  1. 1.
    Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMedGoogle Scholar
  2. 2.
    Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol. 2006;12:17–20.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Hudler P. Genetic aspects of gastric cancer instability. ScientificWorldJournal. 2012;2012:761909.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Ouakaa-Kchaou A, Elloumi H, Gargouri D, Kharrat J, Ghorbel A. Helicobacter pylori and gastric cancer. Tunis Med. 2010;88:459–61.PubMedGoogle Scholar
  5. 5.
    Dalgleish AG, O’Byrne K. Inflammation and cancer: the role of the immune response and angiogenesis. Cancer Treat Res. 2006;130:1–38.CrossRefPubMedGoogle Scholar
  6. 6.
    Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest. 2007;117:1175–83.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Vivier E, Spits H, Cupedo T. Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair? Nat Rev Immunol. 2009;9:229–34.CrossRefPubMedGoogle Scholar
  8. 8.
    Wolk K, Witte E, Witte K, Warszawska K, Sabat R. Biology of interleukin-22. Semin Immunopathol. 2010;32:17–31.CrossRefPubMedGoogle Scholar
  9. 9.
    Wolk K, Sabat R. Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev. 2006;17:367–80.CrossRefPubMedGoogle Scholar
  10. 10.
    Suh JS, Cho SH, Chung JH, Moon A, Park YK, et al. A polymorphism of interleukin-22 receptor alpha-1 is associated with the development of childhood IgA nephropathy. J Interferon Cytokine Res. 2013;33:571–7.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Saeki H, Hirota T, Nakagawa H, Tsunemi Y, Kato T, et al. Genetic polymorphisms in the IL22 gene are associated with psoriasis vulgaris in a Japanese population. J Dermatol Sci. 2013;71:148–50.CrossRefPubMedGoogle Scholar
  12. 12.
    Ding GG, Zhang GL, Chen XC, Zhang MX, Yang L, et al. A study on the relationship between single nucleotide polymorphisms of interleukin-22 and susceptibility to pulmonary tuberculosis. Zhonghua Jie He He Hu Xi Za Zhi. 2012;35:596–600.PubMedGoogle Scholar
  13. 13.
    Wang M, Zhang R, He J, Qiu L, Li J, et al. Potentially functional variants of PLCE1 identified by GWASs contribute to gastric adenocarcinoma susceptibility in an eastern Chinese population. PLoS One. 2012;7:e31932.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Eun YG, Shin IH, Lee YC, Shin SY, Kim SK, et al. Interleukin 22 polymorphisms and papillary thyroid cancer. J Endocrinol Investig. 2013;36:584–7.Google Scholar
  15. 15.
    Thompson CL, Plummer SJ, Tucker TC, Casey G, Li L. Interleukin-22 genetic polymorphisms and risk of colon cancer. Cancer Causes Control. 2010;21:1165–70.CrossRefPubMedGoogle Scholar
  16. 16.
    Musolino C, Allegra A, Ferraro M, Aguennouz M, Russo S, et al. Involvement of T2677T multidrug resistance gene polymorphism in Interleukin 22 plasma concentration in B-chronic lymphocytic leukemia patients. Acta Oncol. 2012;51:406–8.CrossRefPubMedGoogle Scholar
  17. 17.
    Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17:3077–9.CrossRefPubMedGoogle Scholar
  18. 18.
    Zhai Y, Zhou G, Deng G, Xie W, Dong X, et al. Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers. Gastroenterology. 2006;130:2001–9.CrossRefPubMedGoogle Scholar
  19. 19.
    de Bakker PI, Yelensky R, Pe’er I, Gabriel SB, Daly MJ, et al. Efficiency and power in genetic association studies. Nat Genet. 2005;37:1217–23.CrossRefPubMedGoogle Scholar
  20. 20.
    Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68:978–89.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Weber GF, Gaertner FC, Erl W, Janssen KP, Blechert B, et al. IL-22-mediated tumor growth reduction correlates with inhibition of ERK1/2 and AKT phosphorylation and induction of cell cycle arrest in the G2-M phase. J Immunol. 2006;177:8266–72.CrossRefPubMedGoogle Scholar
  22. 22.
    Aujla SJ, Kolls JK. IL-22: a critical mediator in mucosal host defense. J Mol Med (Berl). 2009;87:451–4.CrossRefGoogle Scholar
  23. 23.
    Lejeune D, Dumoutier L, Constantinescu S, Kruijer W, Schuringa JJ, et al. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J Biol Chem. 2002;277:33676–82.CrossRefPubMedGoogle Scholar
  24. 24.
    Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, et al. IL-22 increases the innate immunity of tissues. Immunity. 2004;21:241–54.CrossRefPubMedGoogle Scholar
  25. 25.
    Kim K, Kim G, Kim JY, Yun HJ, Lim SC, et al. Interleukin-22 promotes epithelial cell transformation and breast tumorigenesis via MAP3K8 activation. Carcinogenesis. 2014;35:1352–61.CrossRefPubMedGoogle Scholar
  26. 26.
    Qin S, Ma S, Huang X, Lu D, Zhou Y, et al. Th22 cells are associated with hepatocellular carcinoma development and progression. Chin J Cancer Res. 2014;26:135–41.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Fukui H, Zhang X, Sun C, Hara K, Kikuchi S, et al. IL-22 produced by cancer-associated fibroblasts promotes gastric cancer cell invasion via STAT3 and ERK signaling. Br J Cancer. 2014;111:763–71.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Yu B, Guan M, Peng Y, Shao Y, Zhang C, et al. Copy number variations of interleukin-17F, interleukin-21, and interleukin-22 are associated with systemic lupus erythematosus. Arthritis Rheum. 2011;63:3487–92.CrossRefPubMedGoogle Scholar
  29. 29.
    Prans E, Kingo K, Traks T, Silm H, Vasar E, et al. Copy number variations in IL22 gene are associated with Psoriasis vulgaris. Hum Immunol. 2013;74:792–5.CrossRefPubMedGoogle Scholar
  30. 30.
    Zhang G, Chen X, Chan L, Zhang M, Zhu B, et al. An SNP selection strategy identified IL-22 associating with susceptibility to tuberculosis in Chinese. Sci Rep. 2011;1:20.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Liu F, Pan X, Zhou L, Zhou J, Chen B, et al. Genetic polymorphisms and plasma levels of interleukin-22 contribute to the development of nonsmall cell lung cancer. DNA Cell Biol. 2014:33:705–14.Google Scholar
  32. 32.
    Scarel-Caminaga RM, Curtis KM, Renzi R, Sogumo PM, Anovazzi G, et al. Variation in the CXCR1 gene (IL8RA) is not associated with susceptibility to chronic periodontitis. J Negat Results Biomed. 2011;10:14.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  • Shan-yu Qin
    • 1
  • Xian-wen Yang
    • 1
  • Wei Luo
    • 1
  • Mei Chen
    • 1
  • Zhi-ling Liu
    • 1
  • Si-biao Su
    • 1
  • Hai-xing Jiang
    • 1
  1. 1.Department of GastroenterologyThe First Affiliated Hospital of Guangxi Medical UniversityNanningPeople’s Republic of China

Personalised recommendations